Business Breakdowns – Agilent: Back To The Lab
In the press•Published date 24 July 2025
Marc de Vos, Fund Manager for the Troy Multi-Asset Strategy, joins Matthew Reustle, CFA, on Business Breakdowns to discuss Agilent Technologies.
The episode explores Agilent’s evolution from HP spin-off to a key player in life sciences, and how its recurring revenue model and role in mRNA therapeutics support long-term growth.